Harris 2024 Chapter 15 Excerpts Pp. 375-383. Study chapter 23 wwii, pp. Incident or worsening nephropathy occurred in 525 of 4124 patients (12.7%) in the empagliflozin group and in 388 of 2061 (18.8%) in the placebo group.
Learn faster with spaced repetition. Study chapter 23 wwii, pp.
Learn Faster With Spaced Repetition.
Incident or worsening nephropathy occurred in 525 of 4124 patients (12.7%) in the empagliflozin group and in 388 of 2061 (18.8%) in the placebo group.
Study Chapter 23 Wwii, Pp.
Harris 2024 Chapter 15 Excerpts Pp. 375-383 Images References :
Incident Or Worsening Nephropathy Occurred In 525 Of 4124 Patients (12.7%) In The Empagliflozin Group And In 388 Of 2061 (18.8%) In The Placebo Group.
Study chapter 23 wwii, pp.